Literature DB >> 29473461

Primary aldosteronism and thyroid disorders in atrial fibrillation: A Swedish nationwide case-control study.

Georgios Mourtzinis1,2, Samuel Adamsson Eryd1,3, Annika Rosengren1,3, Lena Björck1,3, Martin Adiels4, Gudmundur Johannsson5,6, Karin Manhem1,2.   

Abstract

Background Atrial fibrillation is associated with hyperthyroidism. Patients with primary aldosteronism have an increased prevalence of atrial fibrillation. However, the prevalence of primary aldosteronism in the atrial fibrillation population is unknown. Aim This nationwide case-control study aimed to compare the prevalence of primary aldosteronism and thyroid disorders in patients with atrial fibrillation with that of age- and sex-matched controls. Methods We identified all atrial fibrillation cases in Sweden between 1987 and 2013 ( n = 713,569) by using the Swedish National Patient Register. A control cohort without atrial fibrillation was randomly selected from the Swedish Total Population Register with a case to control ratio of 1:2. This control cohort was matched for age, sex and place of birth ( n = 1,393,953). Results The prevalence of primary aldosteronism in December 2013 was 0.056% in the atrial fibrillation cohort and 0.024% in controls. At the same time, the prevalence of hypothyroidism was 5.9% in the atrial fibrillation cohort and 3.7% in controls. The prevalence of hyperthyroidism was 2.3% in the atrial fibrillation cohort and 0.8% in controls. Conclusion This study shows, for the first time, a doubled prevalence of primary aldosteronism in a large cohort of patients with atrial fibrillation compared with the general population. There is also an increased prevalence of hypo- and hyper-thyroidism in patients with atrial fibrillation compared with the general population.

Entities:  

Keywords:  Atrial fibrillation; hyperthyroidism; hypothyroidism; prevalence; primary aldosteronism

Mesh:

Year:  2018        PMID: 29473461     DOI: 10.1177/2047487318759853

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  3 in total

Review 1.  Atrial Fibrillation and Aortic Ectasia as Complications of Primary Aldosteronism: Focus on Pathophysiological Aspects.

Authors:  Martina Bollati; Chiara Lopez; Fabio Bioletto; Federico Ponzetto; Ezio Ghigo; Mauro Maccario; Mirko Parasiliti-Caprino
Journal:  Int J Mol Sci       Date:  2022-02-14       Impact factor: 5.923

Review 2.  Characterization, Pathogenesis, and Clinical Implications of Inflammation-Related Atrial Myopathy as an Important Cause of Atrial Fibrillation.

Authors:  Milton Packer
Journal:  J Am Heart Assoc       Date:  2020-04-03       Impact factor: 5.501

3.  Correlations between low thyroid function and incidence of atrial fibrillation in hypertrophic obstructive cardiomyopathy.

Authors:  Li-Min Liu; Li-Shui Shen; Shang-Yu Liu; Bin Tu; Guo-Liang Li; Feng Hu; Zhi-Cheng Hu; Ling-Min Wu; Xiao-Han Fan; Li-Hui Zheng; Li-Gang Ding; Yan Yao
Journal:  Chronic Dis Transl Med       Date:  2020-03-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.